Stocks · Healthcare · Medical - Healthcare Information Services
Health Catalyst, Inc. HCAT
$1.76 +0.57% Close, Oct 5, 2026 · NASDAQ · Market cap $129.3M
High risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -19.7% from -28.0% a year earlier.
- The stock is 49% below its highest close of the past year.
- Over the past year the stock returned -37.1%, behind the S&P 500 by 52.9 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 21%
- Revenue growth, 3-year CAGRBottom 35%
- Revenue growth accelerationBottom 26%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 49%
- Gross marginBottom 31%
- Operating marginBottom 43%
- Accruals (lower is better)Top 3%
- Interest coverBottom 46%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 2%
- Free-cash-flow yieldTop 8%
- EBITDA / enterprise valueBottom 7%
- Sales / enterprise valueTop 7%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 12%
- 6-month returnTop 20%
- 1-year return vs S&P 500Bottom 17%
- Distance from 52-week highBottom 26%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 16%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 16%
- Upside to consensus price targetBottom 12%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 19%
- Maximum drawdown, 3 yearsBottom 13%
- Beta vs S&P 500 (lower is better)Bottom 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -2.8% | -7.5% | ↓ |
| Gross margin | 45.3% | 46.4% | ↑ |
| Operating margin | -28.0% | -19.7% | ↑ |
| FCF margin | -5.0% | 4.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -7.5% | -2.8% | ↓ | Bottom 21% |
| Gross margin | 46.4% | 45.3% | ↑ | Bottom 31% |
| Operating margin | -19.7% | -28.0% | ↑ | Bottom 43% |
| Net margin | -90.6% | -31.7% | ↓ | — |
| Free-cash-flow margin | 4.5% | -5.0% | ↑ | — |
| Return on invested capital | -21.1% | — | Bottom 49% | |
| Revenue growth, 3-year CAGR | 4.0% | — | Bottom 35% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -81.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 6.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -31.2 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -2.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.67%
- Shareholder yield
- -0.67%
- Share count change, 1 year
- +6.2%
- Share count change, 3-year CAGR
- +9.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +35.7%
- Average 2-day reaction, last 8
- -1.9%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $1.77
- Target vs current price
- +0.6%
- Analysts with a rating
- 22
- Share rating Buy or Strong Buy
- 50%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +33.9% | -3.3% | -25.1% | -29.3% | — |
| May 11, 2026 | +100.0% | -9.2% | -21.7% | +15.1% | +57.2% |
| Mar 12, 2026 | -11.1% | -3.8% | -37.6% | -45.7% | +3.8% |
| Nov 10, 2025 | +20.0% | +0.7% | -19.8% | -6.7% | -26.1% |
| Aug 7, 2025 | +33.3% | -3.4% | -15.7% | -13.6% | -14.1% |
| May 7, 2025 | +0.0% | -2.5% | +5.4% | -2.9% | -13.5% |
| Feb 26, 2025 | -63.6% | -0.2% | -8.7% | -9.7% | -24.4% |
| Nov 6, 2024 | -30.0% | +6.3% | +4.8% | +2.2% | -27.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.04 | $0.03 | +33.9% | $70.5M |
| May 11, 2026 | $0.02 | $0.01 | +100.0% | $70.8M |
| Mar 12, 2026 | $0.08 | $0.09 | -11.1% | $74.7M |
| Nov 10, 2025 | $0.06 | $0.05 | +20.0% | $76.3M |
| Aug 7, 2025 | $0.04 | $0.03 | +33.3% | $80.7M |
| May 7, 2025 | $0.01 | $0.01 | +0.0% | $79.4M |
| Feb 26, 2025 | $0.04 | $0.11 | -63.6% | $79.6M |
| Nov 6, 2024 | $0.07 | $0.10 | -30.0% | $76.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 0.82× | — | — | Top 7% |
| Free-cash-flow yield | 10.10% | — | — | Top 8% |
| Earnings yield | -209.09% | — | — | Bottom 2% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.2%
- 200-day average slope (20 days)
- -4.3%
- Distance from 50-day average
- -2.4%
- Distance from 200-day average
- -1.0%
- RSI (14)
- 50.4
- Relative volume
- 0.50×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 78.1%
- Volatility vs own 5-year history
- 66th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.36
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -49.1%
- Maximum drawdown, 3 years
- -91.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 8, 2021 | Apr 10, 2026 | -98.3% | 1215 days | Not yet recovered |
| Apr 29, 2021 | May 17, 2021 | -18.7% | 12 days | 15 days (Jun 8, 2021) |
| Feb 9, 2021 | Mar 29, 2021 | -14.9% | 33 days | 18 days (Apr 23, 2021) |
| Oct 1, 2020 | Oct 21, 2020 | -13.7% | 14 days | 32 days (Dec 7, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $129.3M
- EPS, diluted (TTM)
- -$3.68
- Revenue (TTM)
- $292.2M
- 52-week range
- $0.96 – $3.62
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $241.9M | $276.2M | $295.9M | $306.6M | $311.1M |
| Gross profit | $117.6M | $133.2M | $131.8M | $140.8M | $104.1M |
| Operating income | -$143.7M | -$140.0M | -$126.9M | -$69.8M | -$36.1M |
| Net income | -$153.2M | -$137.4M | -$118.1M | -$69.5M | -$178.0M |
| EPS (diluted) | -$3.23 | -$2.54 | -$2.09 | -$1.15 | -$2.55 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76.4M | $79.6M | $79.4M | $80.7M | $76.3M | $74.7M | $70.8M | $70.5M |
| Net income | -$14.7M | -$20.7M | -$23.7M | -$41.0M | -$22.2M | -$91.0M | -$111.0M | -$40.5M |
| EPS (diluted) | -$0.24 | -$0.33 | -$0.35 | -$0.59 | -$0.32 | -$1.28 | -$1.53 | -$0.55 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$23.1M | -$35.3M | -$33.1M | $14.6M | $731,000 |
| Capital expenditure | -$18.5M | -$17.4M | -$14.3M | -$16.4M | -$968,000 |
| Free cash flow | -$41.6M | -$52.7M | -$47.4M | -$1.8M | -$237,000 |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $245.2M | -$1.3M | -$1.8M | $2.6M | -$3.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $103.4M
- Total assets
- $358.6M
- Total liabilities
- $257.8M
- Total debt
- $170.0M
- Net debt
- $109.4M
- Shareholders’ equity
- $100.8M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 2,028,738
- Days to cover
- 3.93
- Change vs previous report
- +4.0%
FINRA short interest, settlement date Sep 15, 2026.